Brain Processes Involved in Placebo Response in Depression
About this title
Read the official source — NCT02562430Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.
Understand this study
What did researchers investigate?
Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 76
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02562430
- Official title
Show the full official title
Neurobiological Underpinnings of Placebo Response in Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Boston
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Welbutrin XL and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
